1. Acknowledgment

   Acknowledgments 17 August 2012 Pages: 351 - 352

2. Potential Interaction between Clopidogrel and Proton Pump Inhibitors

   • Patricia A. Howard
   • James L. Vacek

   Current Opinion 17 August 2012 Pages: 353 - 359

3. Non-Atheroprotective Effects of Statins

   • Abhimanyu Beri
   • Neethi Sural
   • Snigdha B. Mahajan

   Review Article 17 August 2012 Pages: 361 - 370

   

4. Changes in Endothelial Dysfunction and Associated Cardiovascular Disease Morbidity Markers in GH-IGF Axis Pathology

   • Michael R. Graham
   • Peter Evans
   • Julien S. Baker

   Review Article 17 August 2012 Pages: 371 - 381

   

5. The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy

   • Lorenzo Pradelli
   • Sergio Iannazzo
   • Orietta Zaniolo

   Original Research Article 17 August 2012 Pages: 383 - 392

   

6. Examination of the Effect of Implantable Cardioverter-Defibrillators on Health-Related Quality of Life

   • Katia Noyes
   • Ethan Corona
   • Arthur J. Moss

   Original Research Article 17 August 2012 Pages: 393 - 400

   

7. Fenofibric Acid

   • Lily P. H. Yang
   • Gillian M. Keating

   Adis Drug Profile 17 August 2012 Pages: 401 - 409

   

8. Amlodipine/Valsartan/Hydrochlorothiazide

   • Emma D. Deeks

   Adis Drug Profile 17 August 2012 Pages: 411 - 418